does blue cross blue shield of texas cover semaglutide Prescription Drugs Overview UT SELECT Medical Plan Guide

2009 Nov;10(16):2697-707

Oramed Pharmaceuticals Inc

The Congressional Budget Office (CBO) has stated, "The developing market for [anti-obesity medications] could significantly affect health care spending and the federal budget." They contend that passage of the Treat and Reduce Obesity Act would increase costs for anti-obesity medications (i.e., because more people would use them) but reduce federal costs for other related health issues

Recommendations could include: (1) avoidance of cold, heavy, or greasy foods, which impede digestive function and are hard to break down

These findings align closely with prior cardiovascular outcome trials and solidify the evidence base by demonstrating consistent benefits in broader patient populations treated in clinical practice